Distinguished in Systemic Sclerosis (SSc)

Dr. Soumya D. Chatterjee

Infectious Disease
840 Walnut St, 
Philadelphia, PA 
Distinguished in Systemic Sclerosis (SSc)
840 Walnut St, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Soumya Chatterjee is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Chatterjee is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Systemic Sclerosis (SSc), Fifth Disease, Helminthiasis, and Secernentea Infections.

His clinical research consists of co-authoring 89 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 23 articles and participated in 5 clinical trials in the study of Systemic Sclerosis (SSc).

Specialties
Infectious Disease
Licenses
Internal Medicine in MO
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

840 Walnut St, Philadelphia, PA 19107
Other Locations
3635 Vista Ave, Saint Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics, and Explore Efficacy of TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis
A Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics, and Explore Efficacy of TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: June 28, 2024
Intervention Type: Biological, Other
Study Drug: Tepezza Anti-IGF-1 Receptor Monoclonal Antibody
Study Phase: Phase 1
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Enrollment Status: Completed
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

89 Total Publications

Painful Hand Swelling With Finger Contractures.
Painful Hand Swelling With Finger Contractures.
Journal: JAMA
Published: October 16, 2025
Similar Doctors
Experienced in Systemic Sclerosis (SSc)
Dr. David M. Cohen
Infectious Disease
Experienced in Systemic Sclerosis (SSc)
Dr. David M. Cohen
Infectious Disease

Infectious Disease Associates PA

33 Omega Dr, Bldg J, 
Newark, DE 
 (35.2 miles away)
302-368-2883
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Cohen is an Infectious Disease provider in Newark, Delaware. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Myelitis, AIDS Dementia Complex, HIV/AIDS, and AIDS Dysmorphic Syndrome. Dr. Cohen is currently accepting new patients.

Experienced in Systemic Sclerosis (SSc)
Dr. Madhvi D. Rana
Infectious Disease
Experienced in Systemic Sclerosis (SSc)
Dr. Madhvi D. Rana
Infectious Disease

Id Care LLC

105 Raider Blvd, Suite 101, 
Hillsborough, NJ 
 (46.3 miles away)
908-281-0221
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Madhvi Rana is an Infectious Disease provider in Hillsborough, New Jersey. Dr. Rana is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Strep Throat, Pneumonia, Sepsis, and Lymphangitis. Dr. Rana is currently accepting new patients.

Experienced in Systemic Sclerosis (SSc)
Dr. Najah I. Doka
Infectious Disease
Experienced in Systemic Sclerosis (SSc)
Dr. Najah I. Doka
Infectious Disease

Id Care LLC

105 Raider Blvd, Suite 101, 
Hillsborough, NJ 
 (46.3 miles away)
908-281-0221
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Najah Doka is an Infectious Disease provider in Hillsborough, New Jersey. Dr. Doka is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). Her top areas of expertise are Sepsis, Pneumonia, COVID-19, and Bacterial Gastroenteritis. Dr. Doka is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chatterjee's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile